3-Fluoromethcathinone
Clinical data
Other names3-FMC, 3- Fluoromethcathinone
Routes of
administration		Oral, intranasal, intravenous
Legal status
Legal status
Identifiers
  • 1-(3-Fluorophenyl)-2-(methylamino)propan-1-one
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC10H12FNO
Molar mass181.210 g·mol−1
3D model (JSmol)
  • FC1=CC=CC(=C1)C(C(C)NC)=O
  • InChI=1S/C10H12FNO/c1-7(12-2)10(13)8-4-3-5-9(11)6-8/h3-7,12H,1-2H3 ☒N
  • Key:PQIBROLLUQSNQI-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

3-Fluoromethcathinone (also known as 3-FMC) is a chemical compound of the phenethylamine, amphetamine, and cathinone classes that has been sold online as a designer drug.[1][2] It is a structural isomer of flephedrone (4-fluoromethcathinone).

3-Fluoroisomethcathinone is produced as a by-product when 3-FMC is synthesized, the activity of this compound is unknown.[3]

Effects

This chemical's effects and safety have not been studied scientifically.[3]

Legal status

In the United States, 3-FMC is Schedule I controlled substance.[4]

In the United Kingdom, 3-FMC is a controlled drug under the cathinone blanket ban.

3-FMC is an Anlage II controlled drug in Germany.

3-FMC is banned in the Czech Republic.[5]

See also

References

  1. ^ Ondra P, Válka I, Knob R, Ginterová P, Maier V (October 2015). "Analysis of Amphetamine-Derived Designer Drugs by Gas Chromatography with Mass Spectrometry". Journal of Analytical Toxicology. 40 (1): 78–85. doi:10.1093/jat/bkv113. PMID 26446487.
  2. ^ Archer RP (March 2009). "Fluoromethcathinone, a new substance of abuse". Forensic Science International. 185 (1–3): 10–20. doi:10.1016/j.forsciint.2008.11.013. PMID 19195800.
  3. ^ a b Two cases of confirmed ingestion of the novel designer compounds: 4-methylmethcathinone (Mephedrone) and 3-fluoromethcathinone Susannah Davies et al.
  4. ^ Schedules of Controlled Substances: Temporary Placement of 10 Synthetic Cathinones Into Schedule I
  5. ^ "Látky, o které byl doplněn seznam č. 4 psychotropních látek (příloha č. 4 k nařízení vlády č. 463/2013 Sb.)" (PDF) (in Czech). Ministerstvo zdravotnictví. Archived from the original (PDF) on 9 March 2016. Retrieved 6 February 2016.
Categories